Tirzepatide 5mg/10mg/15mg/30mg | Dual GIP/GLP-1 Receptor Agonist

Research-grade Tirzepatide, a dual GIP/GLP-1 receptor agonist for metabolic pathway research.

99%+ Purity – Janoshik third-party tested (HPLC verified)
Dual Receptor Agonist – GIP and GLP-1 signaling pathway research
Four Dosage Options – 5mg, 10mg, 15mg, 30mg vials available
Extensively Studied – Subject of SURPASS and SURMOUNT research programs
Long-Acting Design – C20 fatty diacid modification for extended half-life research
Complete Documentation – COA, MSDS, reconstitution protocols included
Cold-Chain Shipping – Worldwide delivery at controlled temperature

⚠️ For laboratory research use only. Not for human consumption. Not a weight-loss or diabetes treatment product.

Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Research Peptide

Tirzepatide (LY3298176) is a synthetic peptide investigated as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is studied for its effects on incretin signaling pathways, metabolic regulation, and energy homeostasis in research models.

Why Researchers Choose Our Tirzepatide

✓ 99%+ Purity – Third-party tested by Janoshik Analytical (HPLC verified)
✓ Dual Receptor Agonist – Targets both GIP and GLP-1 receptors in research models
✓ Four Dosage Options – 5mg, 10mg, 15mg, 30mg vials for flexible research protocols
✓ Extensively Studied – Subject of multiple Phase 3 clinical research programs (SURMOUNT, SURPASS series)
✓ Complete Documentation – COA, MSDS, mass spec reports included
✓ Cold-Chain Logistics – Shipped at controlled temperature to preserve peptide integrity

Mechanism of Action (Research Context)

GLP-1 Receptor Agonism

Tirzepatide is studied for its GLP-1 receptor activation, which in research models influences glucose-dependent insulin secretion, glucagon suppression, and gastric emptying pathways.

GIP Receptor Agonism (Unique Feature)

Unlike single-receptor agonists, Tirzepatide activates GIP receptors, which are investigated for their role in insulin secretion, glucagon modulation, and lipid metabolism in metabolic research.

Synergistic Dual-Incretin Action

The combination of GIP and GLP-1 receptor activation is studied for potential synergistic effects on metabolic signaling pathways not observed with single-hormone agonists.

Extended Half-Life Design

Tirzepatide is engineered with a C20 fatty diacid moiety for albumin binding, studied for its pharmacokinetic profile supporting once-weekly dosing protocols in research.

Common Research Applications

Dual incretin receptor signaling pathway studies
GIP and GLP-1 receptor biology research
Metabolic regulation and energy homeostasis models
Glucose metabolism and insulin secretion research
Appetite regulation pathway investigation
Comparative incretin agonist pharmacology
Long-acting peptide formulation research

Clinical Research Background

Tirzepatide has been investigated in multiple large-scale clinical research programs:

SURPASS Program (Type 2 Diabetes Research)

SURPASS-1 to SURPASS-5: Phase 3 studies evaluating glycemic control mechanisms
SURPASS-2: Head-to-head comparison with semaglutide (GLP-1 agonist)
HbA1c reduction ranges studied: 1.87% to 2.46% from baseline

SURMOUNT Program (Obesity/Metabolic Research)

SURMOUNT-1: 2,539 participants, 72-week study period
SURMOUNT-2: Combined metabolic disorder research model
Body weight changes studied: 5mg (-15.0%), 10mg (-19.5%), 15mg (-20.9%) average reductions

Clinical data provided for research context only. These studies involved pharmaceutical-grade formulations administered under medical supervision.

Product Specifications

Compound Name	Tirzepatide (LY3298176)
Type	Dual GIP/GLP-1 receptor agonist
Molecular Formula	C225H348N48O68
Molecular Weight	4813.47 g/mol
CAS Number	2023788-19-2
Purity	≥99% (HPLC)
Appearance	White lyophilized powder
Available Sizes	5mg, 10mg, 15mg, 30mg per vial
Storage (Powder)	Store at 2-8°C (stable 24 months)
Storage (Reconstituted)	Store at 2-8°C, use within 21 days
Reconstitution	Bacteriostatic water recommended

Quality Assurance & Testing

Third-Party Verified: Every batch tested by Janoshik Analytical
HPLC Purity Analysis: Confirms ≥99% purity
Mass Spectrometry: Molecular weight and sequence verification
GMP Certified Facility: Pharmaceutical-grade synthesis standards
Batch-Specific COA: Certificate of Analysis included with every order
Sterile Processing: Lyophilized under aseptic conditions

Ordering Information

Available Sizes: 5mg, 10mg, 15mg, and 30mg per vial (lyophilized powder).

Bulk Discounts: Tiered pricing for research institutions and volume orders.

Documentation Provided: COA, MSDS, mass spec reports, reconstitution guide.

Shipping: Worldwide cold-chain logistics.

Lead Time: In-stock items ship within 1-3 business days.

⚠️ IMPORTANT – RESEARCH USE ONLY

This product is intended strictly for laboratory research and in-vitro studies only.

NOT for human or animal consumption
NOT a drug, supplement, or weight management product
NOT intended to diagnose, treat, cure, or prevent any disease or condition, including diabetes, obesity, or cardiovascular disease
Purchaser confirms they are a qualified researcher or represent a licensed research institution
Use must comply with all applicable laws and regulations in your jurisdiction

Tirzepatide is the active pharmaceutical ingredient in FDA-approved medications Mounjaro® and Zepbound®. This research-grade material is NOT a pharmaceutical formulation and is NOT for human use. If seeking medical treatment, consult a licensed healthcare provider.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Submit Your Sourcing Request

Related Products

Selank Peptide | Anxiety Relief & Cognitive Support | 5mg/10mg

Epithalon Peptide 10mg/50mg | Telomerase Activator | Research Grad

KPV Peptide 5mg/10mg/30mg | Anti-Inflammatory Tripeptide

GHK-CU Copper Peptide 50mg 100mg Research Grade

Research reference compounds with worldwide delivery. For laboratory use only.

Our Contacts

OUR products

TIRZEPATIDE
RETATRUTIDE
SEMAGLUTIDE
CAGRILINTIDE
AOD9604
BPC-157
TB-500
GHK-CU
ELORALINTIDE

KLOW
KPV
CJC-1295
IPAMORELIN
TESAMORELIN
EPITHALON
NAD+
SELANK
PT-141

OUR COMMITMENT TO QUALITY

⚠️ RESEARCH USE ONLY
All products listed on this website are intended for laboratory and research purposes only. These products are NOT for human or animal consumption, NOT dietary supplements, and NOT intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher and will use these materials in compliance with all applicable laws. These statements have not been evaluated by the FDA.